Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 33,369	$ 26,262
General and administrative	17,324	24,327
Total operating expenses	50,693	50,589
Loss from operations	(50,693)	(50,589)
Other income (expense):
Interest income	3,345	1,171
Interest expense	(3,704)	(577)
Other income	(6)	798
Total other income (expense)	(365)	1,392
Net loss	(51,058)	(49,197)
Unrealized gain (loss) on short-term investments	187	(178)
Comprehensive loss	$ (50,871)	$ (49,375)
Net loss per share of common stock, basic	$ (1.32)	$ (1.3)
Net loss per share of common stock, diluted	$ (1.32)	$ (1.3)
Weighted-average shares used to compute basic net loss per share	38,624,462	37,790,981
Weighted-average shares used to compute diluted net loss per share	38,624,462	37,790,981